|Articles|October 1, 2001
- Pharmaceutical Executive-10-01-2001
- Volume 0
- Issue 0
National Crisis Supercedes Coverage Debate
Efforts to craft a Medicare pharmacy benefit may be sidelined by repercussions from the September attack.
Advertisement
Articles in this issue
almost 25 years ago
National Crisis Supercedes Coverage Debatealmost 25 years ago
PBMs: Merck-Medco in the Hot Seatalmost 25 years ago
A Five-Year Forecast: Clear Seas Ahead?almost 25 years ago
Weak Bones, Strong Marketalmost 25 years ago
Approvals: Novartis’ Silver Liningalmost 25 years ago
Pfizer and others Pitch Inalmost 25 years ago
Oncology: EMEA Approval Lagsalmost 25 years ago
Illegal Sales in Indiaalmost 25 years ago
Health Plan Premiums: Pharma Takes the Blamealmost 25 years ago
Little Elan Becomes a Big DealAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
5